Showing results (31-40 of 413) with videos related to
Sort By:
Pageof 42
Cancer Detection and Prevention|April 11, 2000
The CD44 receptor of the mouse LB T-cell lymphoma: analysis of the isoform repertoire and ligand binding properties by reverse-transcriptase polymerase chain reaction and antisense oligonucleotidesS B Wallach, A Friedmann, D NaorScandinavian Journal of Immunology|November 1, 1984
Auto-delayed-type hypersensitivity induced in immunodeficient mice with modified self-antigens. IV. Characterization of the suppressive T-cell factor that controls the autoreactivity against self-antigensN Tarcic, B Y Klein, D NaorCancer Immunology, Immunotherapy : CII|January 1, 1984
Isolated soluble fractions from the murine B16 melanoma induce primary in vitro syngeneic antitumor responsesB Y Klein, S Frenkel, D NaorImmunology|June 1, 1989
Auto-delayed-type hypersensitivity induced in immunodeficient mice with modified self-antigens. V. Cellular autoreactivity directed against self-H-2Dd subregion mediates the inflammatory responsesN Tarcic, C S David, D NaorJournal of Immunology (Baltimore, Md. : 1950)|May 15, 1993
Blocking lymphoma invasiveness with a monoclonal antibody directed against the beta-chain of the leukocyte adhesion molecule (CD18)M A Zahalka, E Okon, D NaorEuropean Journal of Immunology|July 1, 1976
Induction of immune responsiveness in a genetically low-responsive tumor-host combination by chemical modification of the immunogenN Galili, D Naor, B Asjö, et al.Journal of Autoimmunity|June 1, 1989
T-cell clone anti-clone interactions. Effects on suppressor and helper activitiesD Naor, G Essery, M Kahan, et al.Scandinavian Journal of Immunology|February 1, 1984
Auto-delayed-type hypersensitivity induced in immunodeficient mice with syngeneic modified self-antigens. II. Suppressor T cells control the autoimmune responseN Tarcic, R Sharon, E Rosenmann, et al.Immunobiology|January 1, 1981
Immune response to weakly immunogenic virally induced tumors. IX. Mice injected with the in vitro variant of YAC tumor (YAC-1) resist lethal doses of the tumorigenic YAC cellsB Devens, O Deutsch, Y Avraham, et al.Advances in Cancer Research|January 1, 1997
CD44: structure, function, and association with the malignant processD Naor, R V Sionov, D Ish-ShalomPageof 42